Literature DB >> 18047813

Serum leptin levels and lipid profiles in patients with allergic rhinitis and mild asthma.

F Erel1, M Gulec, O Kartal, Z Caliskaner, S Ozturk, H Yaman, Y Kurt, E Gocgeldic, F Ors, M Karaayvaz.   

Abstract

BACKGROUND: Despite improved understanding of the pathophysiology of allergic rhinitis and asthma, the effect of serum leptin level is still controversial. Only a few studies have been performed to investigate the serum leptin levels in allergic rhinitis and asthma, and contradictory results have been observed.
OBJECTIVE: We aimed to investigate the association between leptin, lipid profiles and allergic rhinitis and mild asthma, and to determine whether inhaled and/or intranasal steroids affect the leptin levels. PATIENTS AND METHODS: We studied 43 patients with allergic rhinitis (10 of with mild asthma) (mean age 29.81, range 18-45 yr) and 32 volunteers as a control group (mean age 30.53, range 20-45 yr).
RESULTS: Serum leptin levels in patients were 8.49 +/- 10.76 microg/ml, and did not differ from volunteers 5.42 +/- 6.63 microg/ml. (p > 0.05). We found a direct link between increased body mass index (BMI) and serum leptin levels (p = 0.008). No association was seen between leptin and triglyceride, HDL-cholesterol, VLDL-cholesterol, eosinophil, total IgE (p > 0.05); except for total cholesterol and LDL-cholesterol (p < 0.05). Although, no correlation between allergic rhinitis and mild asthma and serum level of leptin was shown, these parameters and age correlations were stronger in female than in male (p = 0.39 for male and p = 0.011 for female), and also found direct link between increased BMI and sex and patients group (p = 0.008 for male and p = 0.0001 for female). We also determined that there was no effect of inhaled and/or intranasal steroids statistically on serum leptin levels.
CONCLUSION: Our data demonstrate that the serum levels of leptin and lipid profiles on allergic rhinitis and mild asthma were not different than those in controls.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18047813     DOI: 10.1157/13112988

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  4 in total

Review 1.  Leptin as regulator of pulmonary immune responses: involvement in respiratory diseases.

Authors:  Juanita H J Vernooy; Niki D J Ubags; Guy G Brusselle; Jan Tavernier; Benjamin T Suratt; Guy F Joos; Emiel F M Wouters; Ken R Bracke
Journal:  Pulm Pharmacol Ther       Date:  2013-03-27       Impact factor: 3.410

2.  Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Authors:  Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

3.  Increased IL-4 mRNA expression and poly-aromatic hydrocarbon concentrations from children with asthma.

Authors:  Nasser M Al-Daghri; Sherif Abd-Alrahman; Hossam Draz; Khalid Alkharfy; Abdul Khader Mohammed; Mario S Clerici; Majed S Alokail
Journal:  BMC Pediatr       Date:  2014-01-23       Impact factor: 2.125

4.  Dyslipidemia among allergic rhinitis patients: Frequency and risk factors.

Authors:  Dina S Sheha; Lobna A El-Korashi; Amany M AbdAllah; Marwa M El-Begermy; Amira R Elmahdi
Journal:  World Allergy Organ J       Date:  2021-03-05       Impact factor: 4.084

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.